Litcius/Paper detail

The Pathogenesis and Diagnosis of Pneumocystis jiroveci Pneumonia

Anna Apostolopoulou, Jay A. Fishman

2022Journal of Fungi86 citationsDOIOpen Access PDF

Abstract

Pneumocystis jiroveci remains an important fungal pathogen in immunocompromised hosts. The environmental reservoir remains unknown. Pneumonia (PJP) results from airborne transmission, including in nosocomial clusters, or with reactivation after an inadequately treated infection. Pneumocystis pneumonia most often occurs within 6 months of organ transplantation, with intensified or prolonged immunosuppression, notably with corticosteroids and following cytomegalovirus (CMV) infections. Infection may be recognized during recovery from neutropenia and lymphopenia. Invasive procedures may be required for early diagnosis and therapy. Despite being a well-established entity, aspects of the pathogenesis of PJP remain poorly understood. The goal of this review is to summarize the data on the pathogenesis of PJP, review the strengths and weaknesses of the pertinent diagnostic modalities, and discuss areas for future research.

Topics & Concepts

ImmunosuppressionPneumoniaPathogenesisImmunologyIntensive care medicineCytomegalovirusPneumocystosisMedicineNeutropeniaOrgan transplantationTransplantationPneumocystis jiroveciiPneumocystis cariniiHuman immunodeficiency virus (HIV)Viral diseaseHerpesviridaeInternal medicineToxicityPneumocystis jirovecii pneumonia detection and treatmentHIV/AIDS drug development and treatmentSynthesis and Biological Evaluation
The Pathogenesis and Diagnosis of Pneumocystis jiroveci Pneumonia | Litcius